Patrick P. Grace
Director, Chemed Corporation.
Companies
- Chemed CorporationBoard member Jan 30, 2004 to now1
- Tonix PharmaceuticalsBoard member Jan 14, 2013 to May 8, 20192
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Chemed Corporation CHE3,533 shares3$1.8M at $507.68Jul 31, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 31, 2026Sold 190 shares at $532.00 of Chemed Corporation3
- May 18, 2026Granted 386 shares at $440.77 of Chemed Corporation4
- May 8, 2026Sold 60 shares at $425.78 of Chemed Corporation5
- Sep 9, 2025Sold 150 shares at $463.39 of Chemed Corporation6
- May 19, 2025Granted 277 shares at $579.04 of Chemed Corporation7
- Jun 12, 2024Sold 284 shares at $540.98 of Chemed Corporation8
- May 20, 2024Granted 284 shares at $564.34 of Chemed Corporation9
- May 26, 2023Sold 294 shares at $544.24 of Chemed Corporation10
- May 15, 2023Granted 294 shares at $545.69 of Chemed Corporation11
- Jun 10, 2022Sold 262 shares at $465.47 of Chemed Corporation12
- May 16, 2022Granted 262 shares at $496.25 of Chemed Corporation13
- Nov 5, 2021Sold 279 shares at $494.28 of Chemed Corporation14
- May 17, 2021Granted 270 shares at $482.66 of Chemed Corporation15
- Jun 18, 2020Sold 200 shares at $451.04 of Chemed Corporation16
- Jun 18, 2020Sold 920 shares at $450.29 of Chemed Corporation16
- Jun 18, 2020Sold 400 shares at $449.48 of Chemed Corporation16
- May 18, 2020Granted 279 shares at $466.43 of Chemed Corporation17
- Aug 7, 2019Sold 257 shares at $415.43 of Chemed Corporation18
- May 20, 2019Granted 257 shares at $331.69 of Chemed Corporation19
- Jun 22, 2018Sold 250 shares at $323.76 of Chemed Corporation20
- May 21, 2018Granted 255 shares at $333.75 of Chemed Corporation21
- Oct 2, 2017Sold 500 shares at $201.48 of Chemed Corporation22
- May 15, 2017Granted 418 shares at $203.52 of Chemed Corporation23
- Nov 28, 2016Sold 400 shares at $148.53 of Chemed Corporation24
- May 16, 2016Granted 475 shares at $126.53 of Chemed Corporation25
Trade performance
| Date | Stock | Trade | Value | Return since | Vs S&P since | Vs S&P, 1 year |
|---|---|---|---|---|---|---|
| Jul 31, 2026 | CHE | Sale | $101.1K | −3.7% | +7.0% | |
| May 8, 2026 | CHE | Sale | $25.5K | +20.8% | −16.1% | |
| Sep 9, 2025 | CHE | Sale | $69.5K | +10.7% | +8.0% | +5.2% |
| Jun 12, 2024 | CHE | Sale | $153.6K | −5.3% | +47.9% | +8.4% |
| May 26, 2023 | CHE | Sale | $160.0K | −5.5% | +89.2% | +25.9% |
| Jun 10, 2022 | CHE | Sale | $122.0K | +10.3% | +87.7% | −3.6% |
| Nov 5, 2021 | CHE | Sale | $137.9K | +3.2% | +61.5% | −16.5% |
| Jun 18, 2020 | CHE | Sale | $684.3K | +13.8% | +133.7% | +28.6% |
| Aug 7, 2019 | CHE | Sale | $106.8K | +21.7% | +146.3% | −4.4% |
Returns are price-only (no dividends), measured from the trade date.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARChemed Corporation, Board member
- 2SEC EDGARTonix Pharmaceuticals, Board member
- 3
- 4SEC EDGARForm 4 filed May 19, 2026
- 5SEC EDGARForm 4 filed May 8, 2026
- 6SEC EDGARForm 4 filed Sep 10, 2025
- 7SEC EDGARForm 4 filed May 20, 2025
- 8SEC EDGARForm 4 filed Jun 13, 2024
- 9SEC EDGARForm 4 filed May 21, 2024
- 10SEC EDGARForm 4 filed May 30, 2023
- 11SEC EDGARForm 4 filed May 16, 2023
- 12SEC EDGARForm 4 filed Jun 13, 2022
- 13SEC EDGARForm 4 filed May 17, 2022
- 14SEC EDGARForm 4 filed Nov 5, 2021
- 15SEC EDGARForm 4 filed May 18, 2021
- 16SEC EDGARForm 4 filed Jun 22, 2020
- 17SEC EDGARForm 4 filed May 19, 2020
- 18SEC EDGARForm 4 filed Aug 7, 2019
- 19SEC EDGARForm 4 filed May 22, 2019
- 20SEC EDGARForm 4 filed Jun 22, 2018
- 21SEC EDGARForm 4 filed May 23, 2018
- 22SEC EDGARForm 4 filed Oct 2, 2017
- 23SEC EDGARForm 4 filed May 16, 2017
- 24SEC EDGARForm 4 filed Nov 28, 2016
- 25SEC EDGARForm 4 filed May 17, 2016